Amedeo Smart

Free Medical Literature Service




  Free Subscription


2 BMC Cancer
1 Br J Dermatol
3 Cancer Lett
1 Eur J Dermatol
1 Int J Clin Pract
24 Int J Dermatol
1 Intern Med
2 J Dermatol
1 J Invest Dermatol
2 Lancet
3 N Engl J Med
9 PLoS One
2 Proc Natl Acad Sci U S A

    BMC Cancer

  1. AL SAAD S, Al Shenawi H, Almarabheh A, Al Shenawi N, et al
    Is laterality in breast Cancer still worth studying? Local experience in Bahrain.
    BMC Cancer. 2022;22:968.
    >> Share

  2. ALLAHYARI A, Ehsanpour A, Ansarinejad N, Mehrzad V, et al
    Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
    BMC Cancer. 2022;22:960.
    >> Share

    Br J Dermatol

  3. SIMPSON EL, Merola JF, Silverberg JI, Reich K, et al
    Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials.
    Br J Dermatol. 2022 Sep 9. doi: 10.1111/bjd.21867.
    >> Share

    Cancer Lett

  4. WANG M, Wei R, Li G, Bi HL, et al
    SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission.
    Cancer Lett. 2022 Aug 20:215871. doi: 10.1016/j.canlet.2022.215871.
    >> Share

  5. WANG Y, Zhou X, Lei Y, Chu Y, et al
    NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A/MEK/ERK/c-Jun/ABCA1 pathway mediated membrane fluidity.
    Cancer Lett. 2022;547:215884.
    >> Share

  6. MEHLICH D, Marusiak AA
    Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease.
    Cancer Lett. 2022 Jun 3:215775. doi: 10.1016/j.canlet.2022.215775.
    >> Share

    Eur J Dermatol

  7. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey
    Eur J Dermatol. 2022;31:521-529.
    >> Share

    Int J Clin Pract

  8. LI L, Zhang Q, Qian C, Lin H, et al
    Impact of Preoperative Magnetic Resonance Imaging on Surgical Outcomes in Women with Invasive Breast Cancer: A Systematic Review and Meta-Analysis.
    Int J Clin Pract. 2022;2022:6440952.
    >> Share

    Int J Dermatol

  9. AMITAY-LAISH I, Solomon-Cohen E, Feuerman H, Didkovsky E, et al
    Facial demodicosis in the immunosuppressed state: a retrospective case series from a tertiary referral center.
    Int J Dermatol. 2022;61:1245-1252.
    >> Share

  10. NICO MMS, Yendo TM, Lourenco SV
    Understanding oral mucosal lesions in dyskeratosis congenita: from interface inflammation to squamous cell carcinoma, an observational report.
    Int J Dermatol. 2022;61:e366-e368.
    >> Share

  11. BARBOSA E, O'Keeffe C, O'Kane M
    Sweet syndrome: a retrospective analysis of 16 patients from a tertiary care center.
    Int J Dermatol. 2022;61:e391-e393.
    >> Share

  12. CHEN ZM, Wu LM, Ismail F, Hao YY, et al
    Haber's syndrome: report of two Chinese families.
    Int J Dermatol. 2022;61:e378-e380.
    >> Share

  13. HIRAIWA T, Hanami Y, Okiyama N, Konishi R, et al
    Clinically amyopathic dermatomyositis with diffuse erosive erythema in a patient with anti-small ubiquitin-like modifier activating enzyme antibody.
    Int J Dermatol. 2022;61:e389-e391.
    >> Share

  14. PESQUE D, Tormo-Mainar S, Bach R, Recuero-Borau J, et al
    Switching PARP inhibitors as an effective approach for niraparib-induced erythema multiforme.
    Int J Dermatol. 2022;61:e407-e408.
    >> Share

  15. MINTOFF D, Benhadou F, Pace NP, Frew JW, et al
    Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects.
    Int J Dermatol. 2022;61:1175-1186.
    >> Share

  16. GHANIAN S, Dalla Costa R, Singer H, Robinson-Bostom L, et al
    Extensive lues maligna syphilis in an immunocompromised male.
    Int J Dermatol. 2022;61:e410-e411.
    >> Share

  17. NOSEWICZ J, Nash J
    Resolution of post-zoster granulomatous dermatitis with valacyclovir.
    Int J Dermatol. 2022 Sep 13. doi: 10.1111/ijd.16426.
    >> Share

  18. IRIARTE C, Marks DH
    Cutaneous schistosomiasis: epidemiological and clinical characteristics in returning travelers.
    Int J Dermatol. 2022 Sep 12. doi: 10.1111/ijd.16389.
    >> Share

  19. FRIOUI R, Mokni S, Tabka M, Ounallah A, et al
    Inverse lichen planus and palmoplantar keratoderma induced by imatinib mesylate.
    Int J Dermatol. 2022 Sep 10. doi: 10.1111/ijd.16422.
    >> Share

  20. GKANTI V, Dalamaga M, Papadavid E
    Drug survival of brodalumab is greater in patients with psoriasis and psoriatic arthritis in a real-world setting.
    Int J Dermatol. 2022 Sep 10. doi: 10.1111/ijd.16408.
    >> Share

  21. MOUSSA A, Bennett M, Bhoyrul B, Kazmi A, et al
    Clinical features and treatment outcomes of frontal fibrosing alopecia in men.
    Int J Dermatol. 2022;61:e372-e374.
    >> Share

  22. PANDEY P, Paudyal P, Khadka S, Karn S, et al
    Carcinoma erysipeloides in primary inflammatory breast carcinoma of early pregnancy.
    Int J Dermatol. 2022;61:e387-e389.
    >> Share

  23. HONG AS, Alsharabati M, Jagun O, Howard L, et al
    Two cases of blastic plasmacytoid dendritic cell neoplasm.
    Int J Dermatol. 2022;61:e405-e407.
    >> Share

  24. KIM JH, Uh JA, Lee SK, Kim MS, et al
    A case of facial linear focal elastosis with rare clinical features.
    Int J Dermatol. 2022;61:e401-e403.
    >> Share

  25. FARAG AGA, Helal SG, Labib AZ, Bazid HAS, et al
    Study of calprotectin gene polymorphism and serum level in acne vulgaris patients.
    Int J Dermatol. 2022;61:1262-1269.
    >> Share

  26. CRISAN D, Weins AB, Strilciuc S, Cifrea A, et al
    The sonographic resistivity index: a non-invasive parameter for therapeutic efficacy assessment in psoriatic onychopathy.
    Int J Dermatol. 2022;61:e368-e370.
    >> Share

  27. ALBAGHSI H, AlSaba'a S, Almustafa ZZ
    Blaschko-linear alopecia areata in a child, an exceedingly rare variant.
    Int J Dermatol. 2022;61:e403-e405.
    >> Share

  28. ANDRIANO TM, Benesh G, Babbush KM, Hosgood HD, et al
    Serum inflammatory markers and leukocyte profiles accurately describe hidradenitis suppurativa disease severity.
    Int J Dermatol. 2022;61:1270-1275.
    >> Share

  29. DAGNELIE MA, Poinas A, Dreno B
    What is new in adult acne for the last 2 years: focus on acne pathophysiology and treatments.
    Int J Dermatol. 2022;61:1205-1212.
    >> Share

  30. ABDELKADER HA, Fawzy MM, Nour N, Abdel-Halim MRE, et al
    Eczematous mucinous eccrine nevus: a novel presentation with Meyerson phenomenon.
    Int J Dermatol. 2022;61:1280-1283.
    >> Share

  31. SIL A, Panigrahi A
    "Jellyfish in a sea of red" - a distinct dermoscopic finding in eruptive lingual papillitis.
    Int J Dermatol. 2022;61:e385-e387.
    >> Share

  32. CAKIR A, Bostan E, Kaymaz E
    Erythema annulare centrifugum following SARS-CoV-2 infection in a pediatric patient.
    Int J Dermatol. 2022;61:e408-e410.
    >> Share

    Intern Med

  33. ITOH K, Mitsuke Y, Wakahara M, Yoshioka T, et al
    Aseptic Meningitis after Amenamevir Treatment for Herpes Zoster in the First Branch of the Trigeminal Nerve: A Case Report.
    Intern Med. 2022 Feb 26. doi: 10.2169/internalmedicine.8581.
    >> Share

    J Dermatol

  34. LU YY, Lu CC, Tsai CY, Liu YJ, et al
    Impact of seborrheic dermatitis on osteoporosis risk: A population-based cohort study.
    J Dermatol. 2022 Sep 12. doi: 10.1111/1346-8138.16578.
    >> Share

  35. MIYATA A, Kimura U, Hiruma M, Tanaka M, et al
    An atypical case of cutaneous candidiasis caused by a face mask: With useful dermoscopic findings.
    J Dermatol. 2022 Sep 12. doi: 10.1111/1346-8138.16573.
    >> Share

    J Invest Dermatol

  36. PROCHAZKOVA-CARLOTTI M, Gros A, Richard E, Cherrier F, et al
    Patient-derived xenograft and cell line models of human primary cutaneous diffuse large B cell lymphoma-leg type.
    J Invest Dermatol. 2022 Sep 6. pii: S0022-202X(22)01896.
    >> Share


  37. SMITHY JW, Postow MA
    Adjuvant checkpoint blockade following complete local therapy for melanoma metastases.
    Lancet. 2022 Sep 9. pii: S0140-6736(22)01748.
    >> Share

  38. LIVINGSTONE E, Zimmer L, Hassel JC, Fluck M, et al
    Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
    Lancet. 2022 Sep 9. pii: S0140-6736(22)01654.
    >> Share

    N Engl J Med

  39. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    >> Share

  40. KAHN M, Fleece M
    Rice Bodies in Tenosynovitis Due to Psoriatic Arthritis.
    N Engl J Med. 2022;387:e14.
    >> Share

  41. GROSS ND, Miller DM, Khushalani NI, Divi V, et al
    Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
    N Engl J Med. 2022 Sep 12. doi: 10.1056/NEJMoa2209813.
    >> Share

    PLoS One

  42. BLASDELL KR, McNamara B, O'Brien DP, Tachedjian M, et al
    Environmental risk factors associated with the presence of Mycobacterium ulcerans in Victoria, Australia.
    PLoS One. 2022;17:e0274627.
    >> Share

  43. MEYER SB, Lunnay B, Warin M, Foley K, et al
    Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk.
    PLoS One. 2022;17:e0270936.
    >> Share

  44. MIGHRI N, Mejri N, Boujemaa M, Berrazega Y, et al
    Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
    PLoS One. 2022;17:e0269732.
    >> Share

  45. AL-SANEA MM, Chilingaryan G, Abelyan N, Mamikonyan M, et al
    Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors.
    PLoS One. 2022;17:e0272065.
    >> Share

  46. STAAF J, Aine M
    Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data.
    PLoS One. 2022;17:e0265557.
    >> Share

  47. SPIRA JAO, Borges EL, Guedes ACM, Andrade PGR, et al
    Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview.
    PLoS One. 2022;17:e0274254.
    >> Share

  48. YU Q, Xu C, Wang M, Zhu J, et al
    The preventive and therapeutic effects of probiotics on mastitis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0274467.
    >> Share

  49. LEE C, Kim S, Woo J
    A comparative analysis of factors influencing colorectal cancer's age standardized mortality ratio among Korean women in the hot and cold spots.
    PLoS One. 2022;17:e0273995.
    >> Share

  50. BADIRZADEH A, Najm M, Hemphill A, Alipour M, et al
    Effects of negative air ions (NAIs) on Leishmania major: A novel tool for treatment of zoonotic cutaneous leishmaniasis (ZCL).
    PLoS One. 2022;17:e0274124.
    >> Share

    Proc Natl Acad Sci U S A

  51. KUMAR S, Das S, Sun J, Huang Y, et al
    Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2(+) breast cancer by ceramide-loaded nanoparticles.
    Proc Natl Acad Sci U S A. 2022;119:e2205454119.
    >> Share

  52. AHN SS, Yeo H, Jung E, Lim Y, et al
    FRA1:c-JUN:HDAC1 complex down-regulates filaggrin expression upon TNFalpha and IFNgamma stimulation in keratinocytes.
    Proc Natl Acad Sci U S A. 2022;119:e2123451119.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016